PathMD

PathMD

Search
Skip to content
  • Immunohistochemistry
  • WHO Heme Classification
  • CK7 / CK20 Tables
  • Organ Systems
  • About
Organ Systems, Breast, IHC Panels

Breast – IHC

October 10, 2017 peferguson

There are multiple situations where immunohistochemistry can serve an important role in breast disease.  These include:  differentiation of lesion types (e.g. UTH vs. ADH), identifying invasion (e.g DCIS vs. DCIS with invasion), and predictive/prognostic information (e.g. ER/PR/HER-2).

  • Breast – Normal IHC Staining
  • Breast Specific Markers
  • DCIS vs. Invasion
  • UTH vs. ADH
  • DCIS vs. LCIS
  • Predictive/Prognostic Markers

Share this:

  • Share on X (Opens in new window) X
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Facebook (Opens in new window) Facebook
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
  • Share on LinkedIn (Opens in new window) LinkedIn

Related

Post navigation

Previous PostBreast Lesions and Risk of Developing an Invasive CarcinomaNext PostBreast – Epithelial Proliferations

PathMD E-Mail Signup

Poll

Which of the following markers do you most commonly use to highlight erythroid precursors in bone marrow biopsies?
Results

See our PathMD IHC section for more information on some of these helpful markers.

Search PathMD

Important Links

Cancer Protocols

Am. Board of Path. 

PathMD Blog

PathMD
Proudly powered by WordPress